Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
SoftBank Group
TokyoSeries B–Growth
23 people
Triton Partners
LondonSeed–Growth
105 people
Northzone
LondonSeed–Growth$1M – $50M
40 people
Future Planet Capital
LondonSeed–Growth
35 people
Wellington Management
BostonGrowth–Late Stage$5M – $50M
37 people
Nautic Partners
ProvidenceGrowth$50M – $400M
84 people
lone pine capital
Growth–Late Stage
109 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Sixth Street
San FranciscoGrowth–Late Stage$50M – $2.5B
78 people
Bayern Kapital
LandshutSeed–Late Stage$275K – $55M
46 people
Baird Capital
ChicagoSeed–Late Stage
51 people
WCAS
New YorkGrowth
91 people
Ridgemont Equity
CharlotteGrowth–Late Stage$250M
77 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
71 people
Peterson Venture Partners
Salt Lake CitySeed–Growth$5M – $25M
43 people
Z Venture Capital
TokyoSeed–Late Stage
28 people
Viking Global
StamfordGrowth–Late Stage
61 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
58 people
Silversmith Capital Partners
BostonGrowth$20M – $125M
69 people
IMM Investment Japan
TokyoSeed–Growth
21 people
Nippon Venture Capital
TokyoPre-Seed–Growth$300K – $5M
29 people
Raptor Group
Miami BeachSeed–Late Stage
4 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.
































































































